Time and Covid-19 stress in the lockdown situation: Time free, «Dying» of boredom and sadness.


Journal

PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081

Informations de publication

Date de publication:
2020
Historique:
received: 28 04 2020
accepted: 06 07 2020
entrez: 11 8 2020
pubmed: 11 8 2020
medline: 29 8 2020
Statut: epublish

Résumé

A lockdown of people has been used as an efficient public health measure to fight against the exponential spread of the coronavirus disease (Covid-19) and allows the health system to manage the number of patients. The aim of this study (clinicaltrials.gov NCT00430818) was to evaluate the impact of both perceived stress aroused by Covid-19 and of emotions triggered by the lockdown situation on the individual experience of time. A large sample of the French population responded to a survey on their experience of the passage of time during the lockdown compared to before the lockdown. The perceived stress resulting from Covid-19 and stress at work and home were also assessed, as were the emotions felt. The results showed that people have experienced a slowing down of time during the lockdown. This time experience was not explained by the levels of perceived stress or anxiety, although these were considerable, but rather by the increase in boredom and sadness felt in the lockdown situation. The increased anger and fear of death only explained a small part of variance in the time judgment. The conscious experience of time therefore reflected the psychological difficulties experienced during lockdown and was not related to their perceived level of stress or anxiety.

Identifiants

pubmed: 32776990
doi: 10.1371/journal.pone.0236465
pii: PONE-D-20-12336
pmc: PMC7416923
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0236465

Déclaration de conflit d'intérêts

No authors have competing interests.

Références

Occup Med (Lond). 2012 Dec;62(8):600-5
pubmed: 22965867
Conscious Cogn. 2015 Dec 15;38:165-71
pubmed: 26115594
Emotion. 2010 Dec;10(6):908-14
pubmed: 21171761
Acta Psychol (Amst). 2020 Apr;205:103061
pubmed: 32203734
Psychiatry Res. 2020 Jun;288:112958
pubmed: 32283450
Occup Med (Lond). 2011 Sep;61(6):434-6
pubmed: 21505089
J Affect Disord. 2015 Apr 1;175:359-72
pubmed: 25665496
J Psychol. 2003 Nov;137(6):569-95
pubmed: 14992349
Cognition. 2020 Apr;197:104116
pubmed: 31883966
PLoS One. 2013 Aug 19;8(8):e71658
pubmed: 23977105
Psych J. 2019 Mar;8(1):51-65
pubmed: 30740922
Lancet. 2020 Mar 14;395(10227):912-920
pubmed: 32112714
Int J Environ Res Public Health. 2020 Jul 28;17(15):
pubmed: 32731369
Brain Behav Immun. 2020 Jul;87:124-125
pubmed: 32360603
Pers Soc Psychol Bull. 2008 Mar;34(3):353-65
pubmed: 18272804
Emotion. 2008 Feb;8(1):127-31
pubmed: 18266523
Lancet. 2020 Mar 21;395(10228):931-934
pubmed: 32164834
Behav Processes. 2015 Nov;120:135-40
pubmed: 26440426
PLoS One. 2019 Oct 18;14(10):e0223567
pubmed: 31626645
Int J Cardiol. 2012 Jul 12;158(2):322-5
pubmed: 22608270
Acta Psychol (Amst). 2017 Feb;173:116-121
pubmed: 28040645
Perspect Psychol Sci. 2012 Sep;7(5):482-95
pubmed: 26168505
Lancet Psychiatry. 2020 Jun;7(6):547-560
pubmed: 32304649
Front Psychol. 2015 Aug 17;6:1208
pubmed: 26347679
Neurosci Biobehav Rev. 2016 May;64:403-20
pubmed: 26972824
Gen Psychiatr. 2020 Mar 6;33(2):e100213
pubmed: 32215365
Immunol Res. 2014 May;58(2-3):193-210
pubmed: 24798553
Brain Cogn. 2005 Dec;59(3):236-45
pubmed: 16168546
Behav Processes. 2011 Jan;86(1):88-93
pubmed: 20971168
Acta Psychol (Amst). 2015 Mar;156:77-82
pubmed: 25701720
Front Psychol. 2016 Feb 19;7:176
pubmed: 26925006
J Pers Soc Psychol. 1999 May;76(5):805-19
pubmed: 10353204

Auteurs

Sylvie Droit-Volet (S)

Université Clermont Auvergne, CNRS, LAPSCO, Clermont-Ferrand, France.

Sandrine Gil (S)

Université de Poitiers, CNRS, UMR 7295, Poitiers, France.

Natalia Martinelli (N)

Université Clermont Auvergne, CNRS, LAPSCO, Clermont-Ferrand, France.

Nicolas Andant (N)

University Hospital of Clermont Ferrand, CHU Clermont-Ferrand, Clinical Research and Innovation Direction - Biostatistics, Clermont-Ferrand, France.

Maélys Clinchamps (M)

University Hospital of Clermont Ferrand, CHU Clermont-Ferrand, Occupational and Environmental Medicine, Clermont-Ferrand, France.

Lénise Parreira (L)

University Hospital of Clermont Ferrand, CHU Clermont-Ferrand, Occupational and Environmental Medicine, Clermont-Ferrand, France.

Karine Rouffiac (K)

University Hospital of Clermont Ferrand, CHU Clermont-Ferrand, Occupational and Environmental Medicine, Clermont-Ferrand, France.

Michael Dambrun (M)

Université Clermont Auvergne, CNRS, LAPSCO, Clermont-Ferrand, France.

Pascal Huguet (P)

Université Clermont Auvergne, CNRS, LAPSCO, Clermont-Ferrand, France.

Benoît Dubuis (B)

Université de Genève, UNIGE, Fondation INARTIS, Genève, Switzerland.

Bruno Pereira (B)

University Hospital of Clermont Ferrand, CHU Clermont-Ferrand, Clinical Research and Innovation Direction - Biostatistics, Clermont-Ferrand, France.

Jean-Baptiste Bouillon (JB)

Université Clermont Auvergne, CNRS, LAPSCO, Physiological and Psychosocial Stress, University Hospital of Clermont-Ferrand, CHU Clermont-Ferrand, Emergency Medicine, Clermont-Ferrand, France.

Frédéric Dutheil (F)

Université Clermont Auvergne, CNRS, LAPSCO, Physiological and Psychosocial Stress, University Hospital of Clermont-Ferrand, CHU Clermont-Ferrand, Occupational and Environmental Medicine, WittyFit, Clermont-Ferrand, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH